##gff-version 3
##sequence-region P02545 1 664
P02545	UniProtKB	Chain	1	661	.	.	.	ID=PRO_0000398835;Note=Prelamin-A/C	
P02545	UniProtKB	Chain	1	646	.	.	.	ID=PRO_0000063810;Note=Lamin-A/C	
P02545	UniProtKB	Propeptide	647	661	.	.	.	ID=PRO_0000398836;Note=Removed in Lamin-A/C form	
P02545	UniProtKB	Propeptide	662	664	.	.	.	ID=PRO_0000403442;Note=Removed in Prelamin-A/C form and in Lamin-A/C form	
P02545	UniProtKB	Domain	31	387	.	.	.	Note=IF rod;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU01188	
P02545	UniProtKB	Domain	428	545	.	.	.	Note=LTD;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU01187	
P02545	UniProtKB	Region	1	130	.	.	.	Note=Interaction with MLIP;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21498514;Dbxref=PMID:21498514	
P02545	UniProtKB	Region	1	33	.	.	.	Note=Head	
P02545	UniProtKB	Region	34	70	.	.	.	Note=Coil 1A	
P02545	UniProtKB	Region	71	80	.	.	.	Note=Linker 1	
P02545	UniProtKB	Region	81	218	.	.	.	Note=Coil 1B	
P02545	UniProtKB	Region	219	242	.	.	.	Note=Linker 2	
P02545	UniProtKB	Region	243	383	.	.	.	Note=Coil 2	
P02545	UniProtKB	Region	384	664	.	.	.	Note=Tail	
P02545	UniProtKB	Motif	417	422	.	.	.	Note=Nuclear localization signal;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P02545	UniProtKB	Site	266	266	.	.	.	Note=Heptad change of phase	
P02545	UniProtKB	Site	325	325	.	.	.	Note=Stutter;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P02545	UniProtKB	Site	330	330	.	.	.	Note=Heptad change of phase	
P02545	UniProtKB	Site	646	647	.	.	.	Note=Cleavage%3B by endoprotease	
P02545	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
P02545	UniProtKB	Modified residue	3	3	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
P02545	UniProtKB	Modified residue	12	12	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:18669648,PMID:20068231,PMID:23186163,PMID:24275569	
P02545	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
P02545	UniProtKB	Modified residue	19	19	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:16964243,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:16964243,PMID:18669648,PMID:20068231,PMID:23186163,PMID:24275569	
P02545	UniProtKB	Modified residue	22	22	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:16964243,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569,ECO:0000269|Ref.9;Dbxref=PMID:16964243,PMID:18669648,PMID:20068231,PMID:23186163,PMID:24275569	
P02545	UniProtKB	Modified residue	32	32	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48678	
P02545	UniProtKB	Modified residue	32	32	.	.	.	Note=N6-succinyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48678	
P02545	UniProtKB	Modified residue	51	51	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P02545	UniProtKB	Modified residue	66	66	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P02545	UniProtKB	Modified residue	71	71	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P02545	UniProtKB	Modified residue	107	107	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P02545	UniProtKB	Modified residue	108	108	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
P02545	UniProtKB	Modified residue	123	123	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48678	
P02545	UniProtKB	Modified residue	135	135	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48678	
P02545	UniProtKB	Modified residue	155	155	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48678	
P02545	UniProtKB	Modified residue	171	171	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48678	
P02545	UniProtKB	Modified residue	171	171	.	.	.	Note=N6-succinyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48678	
P02545	UniProtKB	Modified residue	201	201	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48678	
P02545	UniProtKB	Modified residue	212	212	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:20068231,PMID:23186163,PMID:24275569	
P02545	UniProtKB	Modified residue	260	260	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48678	
P02545	UniProtKB	Modified residue	270	270	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
P02545	UniProtKB	Modified residue	277	277	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:20068231;Dbxref=PMID:17081983,PMID:20068231	
P02545	UniProtKB	Modified residue	301	301	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:18669648,PMID:20068231,PMID:23186163,PMID:24275569	
P02545	UniProtKB	Modified residue	307	307	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
P02545	UniProtKB	Modified residue	311	311	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
P02545	UniProtKB	Modified residue	390	390	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:16964243,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:16964243,PMID:18669648,PMID:20068231,PMID:21406692,PMID:23186163,PMID:24275569	
P02545	UniProtKB	Modified residue	392	392	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:16964243,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:16964243,PMID:18669648,PMID:20068231,PMID:21406692,PMID:23186163	
P02545	UniProtKB	Modified residue	395	395	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:16964243,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:24275569;Dbxref=PMID:16964243,PMID:18669648,PMID:20068231,PMID:24275569	
P02545	UniProtKB	Modified residue	398	398	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P02545	UniProtKB	Modified residue	403	403	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
P02545	UniProtKB	Modified residue	404	404	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:24275569;Dbxref=PMID:20068231,PMID:21406692,PMID:24275569	
P02545	UniProtKB	Modified residue	407	407	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48678	
P02545	UniProtKB	Modified residue	414	414	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:24275569;Dbxref=PMID:20068231,PMID:21406692,PMID:24275569	
P02545	UniProtKB	Modified residue	429	429	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P02545	UniProtKB	Modified residue	431	431	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
P02545	UniProtKB	Modified residue	450	450	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
P02545	UniProtKB	Modified residue	457	457	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48678	
P02545	UniProtKB	Modified residue	458	458	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:18669648,PMID:20068231,PMID:21406692,PMID:23186163,PMID:24275569	
P02545	UniProtKB	Modified residue	463	463	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:20068231,PMID:23186163,PMID:24275569	
P02545	UniProtKB	Modified residue	496	496	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48679	
P02545	UniProtKB	Modified residue	505	505	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
P02545	UniProtKB	Modified residue	510	510	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48679	
P02545	UniProtKB	Modified residue	533	533	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P02545	UniProtKB	Modified residue	546	546	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48678	
P02545	UniProtKB	Modified residue	548	548	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48678	
P02545	UniProtKB	Modified residue	568	568	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48678	
P02545	UniProtKB	Modified residue	571	571	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48678	
P02545	UniProtKB	Modified residue	612	612	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
P02545	UniProtKB	Modified residue	613	613	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P02545	UniProtKB	Modified residue	616	616	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48678	
P02545	UniProtKB	Modified residue	619	619	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P02545	UniProtKB	Modified residue	628	628	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:16964243,ECO:0000244|PubMed:17924679,ECO:0000244|PubMed:18220336,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:16964243,PMID:17924679,PMID:18220336,PMID:18669648,PMID:20068231,PMID:23186163	
P02545	UniProtKB	Modified residue	632	632	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:16964243,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:16964243,PMID:18669648,PMID:18691976,PMID:20068231,PMID:23186163	
P02545	UniProtKB	Modified residue	636	636	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:16964243,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:16964243,PMID:18669648,PMID:20068231,PMID:21406692,PMID:23186163,PMID:24275569	
P02545	UniProtKB	Modified residue	652	652	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231;Dbxref=PMID:18669648,PMID:20068231	
P02545	UniProtKB	Modified residue	661	661	.	.	.	Note=Cysteine methyl ester;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:8175923,ECO:0000269|PubMed:9030603;Dbxref=PMID:8175923,PMID:9030603	
P02545	UniProtKB	Lipidation	661	661	.	.	.	Note=S-farnesyl cysteine;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:8175923,ECO:0000269|PubMed:9030603;Dbxref=PMID:8175923,PMID:9030603	
P02545	UniProtKB	Cross-link	32	32	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P02545	UniProtKB	Cross-link	97	97	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25772364,PMID:28112733	
P02545	UniProtKB	Cross-link	171	171	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P02545	UniProtKB	Cross-link	201	201	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)%3B alternate	
P02545	UniProtKB	Cross-link	201	201	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P02545	UniProtKB	Cross-link	208	208	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:28112733	
P02545	UniProtKB	Cross-link	219	219	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P02545	UniProtKB	Cross-link	233	233	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25114211,ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:28112733;Dbxref=PMID:25114211,PMID:25218447,PMID:25755297,PMID:28112733	
P02545	UniProtKB	Cross-link	260	260	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:28112733;Dbxref=PMID:25755297,PMID:28112733	
P02545	UniProtKB	Cross-link	270	270	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:28112733;Dbxref=PMID:25755297,PMID:28112733	
P02545	UniProtKB	Cross-link	311	311	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25772364,PMID:28112733	
P02545	UniProtKB	Cross-link	366	366	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P02545	UniProtKB	Cross-link	378	378	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25755297,PMID:25772364,PMID:28112733	
P02545	UniProtKB	Cross-link	417	417	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25755297,PMID:28112733	
P02545	UniProtKB	Cross-link	420	420	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25755297,PMID:25772364,PMID:28112733	
P02545	UniProtKB	Cross-link	450	450	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P02545	UniProtKB	Cross-link	470	470	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P02545	UniProtKB	Cross-link	486	486	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P02545	UniProtKB	Cross-link	597	597	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:25114211;Dbxref=PMID:25114211	
P02545	UniProtKB	Cross-link	597	597	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25114211,ECO:0000244|PubMed:28112733;Dbxref=PMID:25114211,PMID:28112733	
P02545	UniProtKB	Alternative sequence	1	99	.	.	.	ID=VSP_053503;Note=In isoform 5. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P02545	UniProtKB	Alternative sequence	1	7	.	.	.	ID=VSP_045977;Note=In isoform 4. METPSQR->MGNSEGC;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
P02545	UniProtKB	Alternative sequence	8	119	.	.	.	ID=VSP_045978;Note=In isoform 4. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
P02545	UniProtKB	Alternative sequence	100	119	.	.	.	ID=VSP_053504;Note=In isoform 5. ARLQLELSKVREEFKELKAR->MDLEAWDPHLEPDAEAMVDG;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P02545	UniProtKB	Alternative sequence	537	566	.	.	.	ID=VSP_002468;Note=In isoform ADelta10. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:8621584;Dbxref=PMID:8621584	
P02545	UniProtKB	Alternative sequence	567	572	.	.	.	ID=VSP_002469;Note=In isoform C. GSHCSS->VSGSRR;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:3453101,ECO:0000303|PubMed:3462705;Dbxref=PMID:15489334,PMID:3453101,PMID:3462705	
P02545	UniProtKB	Alternative sequence	573	664	.	.	.	ID=VSP_002470;Note=In isoform C. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:3453101,ECO:0000303|PubMed:3462705;Dbxref=PMID:15489334,PMID:3453101,PMID:3462705	
P02545	UniProtKB	Alternative sequence	607	656	.	.	.	ID=VSP_053505;Note=In isoform 6. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.4	
P02545	UniProtKB	Alternative sequence	664	664	.	.	.	ID=VSP_045979;Note=In isoform 4. M->IQEMGMRWEVEEGRRKVSLSCLP;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
P02545	UniProtKB	Natural variant	10	10	.	.	.	ID=VAR_039745;Note=In an atypical progeroid patient%3B diagnosed as Seip syndrome%3B unknown pathological significance. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15060110;Dbxref=dbSNP:rs57077886,PMID:15060110	
P02545	UniProtKB	Natural variant	24	24	.	.	.	ID=VAR_076562;Note=In EDMD3. T->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27234031;Dbxref=PMID:27234031	
P02545	UniProtKB	Natural variant	25	25	.	.	.	ID=VAR_039746;Note=In EDMD2. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14684700;Dbxref=dbSNP:rs58327533,PMID:14684700	
P02545	UniProtKB	Natural variant	25	25	.	.	.	ID=VAR_039747;Note=In EDMD2%3B mis-localized in the nucleus%3B causes nuclear deformations and LMNB1 redistribution. R->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11503164,ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs61578124,PMID:11503164,PMID:20848652	
P02545	UniProtKB	Natural variant	28	28	.	.	.	ID=VAR_039748;Note=In FPLD2. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12015247;Dbxref=dbSNP:rs59914820,PMID:12015247	
P02545	UniProtKB	Natural variant	32	32	.	.	.	ID=VAR_039749;Note=In EDMD2%3B abnormal nuclear localization in a honeycomb expression pattern in about 11%25 of cultured skin fibroblasts from heterozygous patients%3B no effect on protein level. Missing;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12467752,ECO:0000269|PubMed:14684700,ECO:0000269|PubMed:15372542;Dbxref=PMID:12467752,PMID:14684700,PMID:15372542	
P02545	UniProtKB	Natural variant	33	33	.	.	.	ID=VAR_039750;Note=In CMT2%3B autosomal dominant form. E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14985400;Dbxref=dbSNP:rs57966821,PMID:14985400	
P02545	UniProtKB	Natural variant	33	33	.	.	.	ID=VAR_039751;Note=In EDMD2. E->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14985400;Dbxref=dbSNP:rs267607614,PMID:14985400	
P02545	UniProtKB	Natural variant	35	35	.	.	.	ID=VAR_039752;Note=In EDMD2. L->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14684700;Dbxref=dbSNP:rs56694480,PMID:14684700	
P02545	UniProtKB	Natural variant	39	39	.	.	.	ID=VAR_063588;Note=In MDCL and EDMD2. N->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18551513,ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs57983345,PMID:18551513,PMID:20848652	
P02545	UniProtKB	Natural variant	43	43	.	.	.	ID=VAR_039753;Note=In EDMD2. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11503164;Dbxref=dbSNP:rs60446065,PMID:11503164	
P02545	UniProtKB	Natural variant	45	45	.	.	.	ID=VAR_009971;Note=In EDMD2. Y->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10939567,ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs58436778,PMID:10939567,PMID:20848652	
P02545	UniProtKB	Natural variant	50	50	.	.	.	ID=VAR_009972;Note=In EDMD2 and MDCL. R->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10939567,ECO:0000269|PubMed:18551513;Dbxref=dbSNP:rs60695352,PMID:10939567,PMID:18551513	
P02545	UniProtKB	Natural variant	50	50	.	.	.	ID=VAR_039754;Note=In EDMD2. R->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11503164;Dbxref=dbSNP:rs59931416,PMID:11503164	
P02545	UniProtKB	Natural variant	57	57	.	.	.	ID=VAR_017656;Note=In CMDHH%3B phenotype originally designated as atypical Werner syndrome. A->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12927431;Dbxref=dbSNP:rs28928903,PMID:12927431	
P02545	UniProtKB	Natural variant	59	59	.	.	.	ID=VAR_064055;Note=In CMDHH. L->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17150192,ECO:0000269|PubMed:19283854;Dbxref=dbSNP:rs58922911,PMID:17150192,PMID:19283854	
P02545	UniProtKB	Natural variant	60	60	.	.	.	ID=VAR_034706;Note=In CMD1A and FPLD2%3B interacts with itself and with wild-type LMNA and LMNB1%3B no decrease in the stability compared with wild-type. R->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10580070,ECO:0000269|PubMed:11792809,ECO:0000269|PubMed:12196663;Dbxref=dbSNP:rs28928900,PMID:10580070,PMID:11792809,PMID:12196663	
P02545	UniProtKB	Natural variant	62	62	.	.	.	ID=VAR_039755;Note=In FPLD2. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12015247;Dbxref=dbSNP:rs56793579,PMID:12015247	
P02545	UniProtKB	Natural variant	63	63	.	.	.	ID=VAR_039756;Note=In EDMD2. I->N;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12467752,ECO:0000269|PubMed:12649505,ECO:0000269|PubMed:15744034;Dbxref=dbSNP:rs57793737,PMID:12467752,PMID:12649505,PMID:15744034	
P02545	UniProtKB	Natural variant	63	63	.	.	.	ID=VAR_009974;Note=In EDMD2%3B no effect on protein level%3B no obvious effect on nuclear morphology in cultured skin fibroblasts from heterozygous patients. I->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10939567,ECO:0000269|PubMed:15372542;Dbxref=dbSNP:rs57793737,PMID:10939567,PMID:15372542	
P02545	UniProtKB	Natural variant	65	65	.	.	.	ID=VAR_039757;Note=In EDMD2. E->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14684700;Dbxref=PMID:14684700	
P02545	UniProtKB	Natural variant	85	85	.	.	.	ID=VAR_009975;Note=In CMD1A%3B interacts with itself and with wild-type LMNA and LMNB1%3B no decrease in the stability compared with wild-type. L->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10580070,ECO:0000269|PubMed:11792809;Dbxref=dbSNP:rs28933090,PMID:10580070,PMID:11792809	
P02545	UniProtKB	Natural variant	89	89	.	.	.	ID=VAR_039758;Note=In CMD1A%3B dramatically aberrant localization with almost no nuclear rim staining and formation of intranuclear foci. R->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12628721,ECO:0000269|PubMed:20160190;Dbxref=dbSNP:rs59040894,PMID:12628721,PMID:20160190	
P02545	UniProtKB	Natural variant	92	92	.	.	.	ID=VAR_067257;Note=In CMD1A. L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21846512;Dbxref=dbSNP:rs267607560,PMID:21846512	
P02545	UniProtKB	Natural variant	97	97	.	.	.	ID=VAR_039759;Note=In CMD1A. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11897440;Dbxref=dbSNP:rs59065411,PMID:11897440	
P02545	UniProtKB	Natural variant	101	101	.	.	.	ID=VAR_070174;Note=In CMD1A%3B dramatically aberrant localization with almost no nuclear rim staining and formation of intranuclear foci. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20160190;Dbxref=dbSNP:rs267607568,PMID:20160190	
P02545	UniProtKB	Natural variant	112	112	.	.	.	ID=VAR_009976;Note=In EDMD2. Missing;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10939567,ECO:0000269|PubMed:14684700;Dbxref=PMID:10939567,PMID:14684700	
P02545	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_072817;Note=Polymorphism%3B found in patients with atrial fibrillation. G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19427440;Dbxref=dbSNP:rs267607605,PMID:19427440	
P02545	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_016913;Note=In FPLD2. R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12629077;Dbxref=dbSNP:rs60864230,PMID:12629077	
P02545	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_017657;Note=In EDMD2. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11503164;Dbxref=dbSNP:rs60864230,PMID:11503164	
P02545	UniProtKB	Natural variant	138	138	.	.	.	ID=VAR_070175;Note=In HGPS%3B might be associated with early and severe strokes. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21791255;Dbxref=dbSNP:rs267607649,PMID:21791255	
P02545	UniProtKB	Natural variant	140	140	.	.	.	ID=VAR_039760;Note=In EDMD2. L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12649505,ECO:0000269|PubMed:15744034;Dbxref=dbSNP:rs60652225,PMID:12649505,PMID:15744034	
P02545	UniProtKB	Natural variant	140	140	.	.	.	ID=VAR_017658;Note=In HGPS%3B phenotype originally designated as atypical Werner syndrome. L->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12927431;Dbxref=dbSNP:rs60652225,PMID:12927431	
P02545	UniProtKB	Natural variant	143	143	.	.	.	ID=VAR_034707;Note=In HGPS. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15622532;Dbxref=dbSNP:rs58912633,PMID:15622532	
P02545	UniProtKB	Natural variant	143	143	.	.	.	ID=VAR_039761;Note=In CMD1A. S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15140538;Dbxref=dbSNP:rs61661343,PMID:15140538	
P02545	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_017659;Note=In HGPS%3B atypical. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12714972;Dbxref=dbSNP:rs60310264,PMID:12714972	
P02545	UniProtKB	Natural variant	150	150	.	.	.	ID=VAR_039762;Note=In EDMD2. T->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10908904,ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs58917027,PMID:10908904,PMID:20848652	
P02545	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_017660;Note=In CMD1A. E->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12920062,ECO:0000269|PubMed:21846512;Dbxref=dbSNP:rs28933093,PMID:12920062,PMID:21846512	
P02545	UniProtKB	Natural variant	166	166	.	.	.	ID=VAR_070176;Note=In CMD1A%3B dramatically aberrant localization with almost no nuclear rim staining and formation of intranuclear foci. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20160190;Dbxref=dbSNP:rs267607570,PMID:20160190	
P02545	UniProtKB	Natural variant	189	189	.	.	.	ID=VAR_064962;Note=In EDMD2%3B found also in a patient with limb-girdle muscular dystrophy%3B sporadic. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs267607643,PMID:20848652	
P02545	UniProtKB	Natural variant	190	190	.	.	.	ID=VAR_039763;Note=In EDMD2 and CMD1A%3B aberrant localization with decreased nuclear rim staining and increased formation of intranuclear foci. R->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15744034,ECO:0000269|PubMed:20160190;Dbxref=dbSNP:rs267607571,PMID:15744034,PMID:20160190	
P02545	UniProtKB	Natural variant	190	190	.	.	.	ID=VAR_064963;Note=In EDMD2. R->RR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20848652;Dbxref=PMID:20848652	
P02545	UniProtKB	Natural variant	190	190	.	.	.	ID=VAR_039764;Note=In CMD1A. R->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11897440,ECO:0000269|PubMed:15219508,ECO:0000269|PubMed:16061563;Dbxref=dbSNP:rs59026483,PMID:11897440,PMID:15219508,PMID:16061563	
P02545	UniProtKB	Natural variant	192	192	.	.	.	ID=VAR_039765;Note=In CMD1A%3B dramatically increases the size of intranuclear speckles and reduces their number%3B this phenotype is only partially reversed by coexpression of the G-192 mutation and wild-type lamin-C%3B precludes insertion of lamin-C into the nuclear envelope when co-transfected with the G-192 LMNA%3B G-192 lamin-C expression totally disrupts the SUMO1 pattern. D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16061563;Dbxref=dbSNP:rs57045855,PMID:16061563	
P02545	UniProtKB	Natural variant	195	195	.	.	.	ID=VAR_009977;Note=In CMD1A%3B dramatically aberrant localization with decreased nuclear rim staining and formation of intranuclear foci%3B distribution of endogenous LMNA%2C LMNB1 and LMNB2 are altered in cells expressing this mutant%3B causes an increased loss of endogenous EMD from the nuclear envelope%3B interacts with itself and with wild-type LMNA and LMNB1%3B no decrease in the stability compared with wild-type. N->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10580070,ECO:0000269|PubMed:11792809;Dbxref=dbSNP:rs28933091,PMID:10580070,PMID:11792809	
P02545	UniProtKB	Natural variant	196	199	.	.	.	ID=VAR_039766;Note=In EDMD2. RLQT->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11503164;Dbxref=PMID:11503164	
P02545	UniProtKB	Natural variant	203	203	.	.	.	ID=VAR_009978;Note=In CMD1A%3B interacts with itself and with wild-type LMNA and LMNB1%3B no decrease in the stability compared with wild-type%3B decreased sumoylation%3B aberrant localization with decreased nuclear rim staining and formation of intranuclear foci%3B associated with increased cell death. E->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10580070,ECO:0000269|PubMed:11792809,ECO:0000269|PubMed:18606848;Dbxref=dbSNP:rs28933092,PMID:10580070,PMID:11792809,PMID:18606848	
P02545	UniProtKB	Natural variant	203	203	.	.	.	ID=VAR_039767;Note=In CMD1A%3B decreased sumoylation%3B aberrant localization with decreased nuclear rim staining and formation of intranuclear foci%3B associated with increased cell death. E->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11561226,ECO:0000269|PubMed:18606848,ECO:0000269|PubMed:20160190;Dbxref=dbSNP:rs61195471,PMID:11561226,PMID:18606848,PMID:20160190	
P02545	UniProtKB	Natural variant	206	206	.	.	.	ID=VAR_064964;Note=In EDMD2. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs267607629,PMID:20848652	
P02545	UniProtKB	Natural variant	208	208	.	.	.	ID=VAR_034708;Note=In EDMD2%3B no obvious effect on nuclear morphology in cultured skin fibroblasts from heterozygous patients%3B no effect on protein level. Missing;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10814726,ECO:0000269|PubMed:15372542;Dbxref=PMID:10814726,PMID:15372542	
P02545	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_070177;Note=In CMD1A%3B dramatically aberrant localization with almost no nuclear rim staining and increased formation of intranuclear foci. I->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20160190;Dbxref=dbSNP:rs267607572,PMID:20160190	
P02545	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_039768;Note=In CMD1A%3B aberrant localization with decreased nuclear rim staining and formation of intranuclear foci. L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12486434,ECO:0000269|PubMed:20160190;Dbxref=dbSNP:rs61295588,PMID:12486434,PMID:20160190	
P02545	UniProtKB	Natural variant	222	222	.	.	.	ID=VAR_039769;Note=In EDMD2. H->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10939567;Dbxref=dbSNP:rs58034145,PMID:10939567	
P02545	UniProtKB	Natural variant	222	222	.	.	.	ID=VAR_009979;Note=In EDMD2. H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10739764;Dbxref=dbSNP:rs28928901,PMID:10739764	
P02545	UniProtKB	Natural variant	225	225	.	.	.	ID=VAR_067697;Note=In EDMD3. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22431096;Dbxref=dbSNP:rs199474724,PMID:22431096	
P02545	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_039770;Note=In FPLD2. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17250669;Dbxref=dbSNP:rs61214927,PMID:17250669	
P02545	UniProtKB	Natural variant	232	232	.	.	.	ID=VAR_039771;Note=In EDMD2. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10939567;Dbxref=dbSNP:rs57207746,PMID:10939567	
P02545	UniProtKB	Natural variant	248	248	.	.	.	ID=VAR_039772;Note=In EDMD2. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14684700;Dbxref=dbSNP:rs58850446,PMID:14684700	
P02545	UniProtKB	Natural variant	249	249	.	.	.	ID=VAR_009980;Note=In EDMD2%3B no obvious effect on nuclear morphology in cultured skin fibroblasts from heterozygous patients%3B no effect on protein level. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10739764,ECO:0000269|PubMed:10939567,ECO:0000269|PubMed:11503164,ECO:0000269|PubMed:12032588,ECO:0000269|PubMed:12649505,ECO:0000269|PubMed:14684700,ECO:0000269|PubMed:15372542,ECO:0000269|PubMed:15744034,ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs59332535,PMID:10739764,PMID:10939567,PMID:11503164,PMID:12032588,PMID:12649505,PMID:14684700,PMID:15372542,PMID:15744034,PMID:20848652	
P02545	UniProtKB	Natural variant	249	249	.	.	.	ID=VAR_063589;Note=In MDCL and EDMD2%3B mislocalized in the nucleus%3B causes nuclear deformations and LMNB1 redistribution. R->W;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18551513,ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs121912496,PMID:18551513,PMID:20848652	
P02545	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_076563;Note=In EDMD2. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27234031;Dbxref=PMID:27234031	
P02545	UniProtKB	Natural variant	260	260	.	.	.	ID=VAR_039773;Note=In CMDA1. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16156025;Dbxref=PMID:16156025	
P02545	UniProtKB	Natural variant	261	261	.	.	.	ID=VAR_009981;Note=In EDMD2. Missing;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10908904,ECO:0000269|PubMed:10939567,ECO:0000269|PubMed:11503164;Dbxref=PMID:10908904,PMID:10939567,PMID:11503164	
P02545	UniProtKB	Natural variant	267	267	.	.	.	ID=VAR_039774;Note=In EDMD2. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14684700;Dbxref=dbSNP:rs57048196,PMID:14684700	
P02545	UniProtKB	Natural variant	268	268	.	.	.	ID=VAR_064965;Note=In EDMD2. S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs267607630,PMID:20848652	
P02545	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_064966;Note=In EDMD2. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs267607641,PMID:20848652	
P02545	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_009982;Note=In EDMD2. Q->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10939567,ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs61616775,PMID:10939567,PMID:20848652	
P02545	UniProtKB	Natural variant	295	295	.	.	.	ID=VAR_064967;Note=In EDMD2. S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs267607633,PMID:20848652	
P02545	UniProtKB	Natural variant	298	298	.	.	.	ID=VAR_017661;Note=In CMT2B1. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11799477;Dbxref=dbSNP:rs59885338,PMID:11799477	
P02545	UniProtKB	Natural variant	300	300	.	.	.	ID=VAR_070178;Note=In HGPS%3B atypical form with late onset%3B abnormal nuclear morphology with single or multple blebs%2C lobulation and occasional ringed or donut shaped nuclei. D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23666920;Dbxref=dbSNP:rs79907212,PMID:23666920	
P02545	UniProtKB	Natural variant	302	302	.	.	.	ID=VAR_063590;Note=In MDCL. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18551513;Dbxref=dbSNP:rs267607596,PMID:18551513	
P02545	UniProtKB	Natural variant	303	303	.	.	.	ID=VAR_064968;Note=In EDMD2. S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs61527854,PMID:20848652	
P02545	UniProtKB	Natural variant	317	317	.	.	.	ID=VAR_039775;Note=In CMD1A. E->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11897440,ECO:0000269|PubMed:21846512;Dbxref=dbSNP:rs56816490,PMID:11897440,PMID:21846512	
P02545	UniProtKB	Natural variant	318	318	.	.	.	ID=VAR_070179;Note=In CMD1A%3B no effect on nuclear morphology and lamin A localization. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20160190;Dbxref=dbSNP:rs267607574,PMID:20160190	
P02545	UniProtKB	Natural variant	336	336	.	.	.	ID=VAR_009983;Note=In EDMD2. R->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10739764,ECO:0000269|PubMed:12467752;Dbxref=dbSNP:rs58105277,PMID:10739764,PMID:12467752	
P02545	UniProtKB	Natural variant	343	343	.	.	.	ID=VAR_009984;Note=In EDMD2. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12467752;Dbxref=dbSNP:rs61177390,PMID:12467752	
P02545	UniProtKB	Natural variant	349	349	.	.	.	ID=VAR_039776;Note=In CMD1A. R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15219508;Dbxref=dbSNP:rs58789393,PMID:15219508	
P02545	UniProtKB	Natural variant	355	355	.	.	.	ID=VAR_064969;Note=In EDMD2. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20848652;Dbxref=PMID:20848652	
P02545	UniProtKB	Natural variant	358	358	.	.	.	ID=VAR_009985;Note=In EDMD2 and MDCL%3B aberrant localization with decreased nuclear rim staining and formation of intranuclear foci when transfected in C2C12 myoblasts%3B no obvious effect on nuclear morphology in cultured skin fibroblasts from heterozygous patients%3B distribution of endogenous LMNA%2C LMNB1 and LMNB2 are altered in cells expressing this mutant%3B interacts with itself and with wild-type LMNA and LMNB1%3B no effect on protein level. E->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10939567,ECO:0000269|PubMed:11503164,ECO:0000269|PubMed:11792809,ECO:0000269|PubMed:15372542,ECO:0000269|PubMed:18551513,ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs60458016,PMID:10939567,PMID:11503164,PMID:11792809,PMID:15372542,PMID:18551513,PMID:20848652	
P02545	UniProtKB	Natural variant	361	361	.	.	.	ID=VAR_064970;Note=In EDMD2. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs267607634,PMID:20848652	
P02545	UniProtKB	Natural variant	371	371	.	.	.	ID=VAR_009986;Note=In EDMD2%3B dramatically aberrant localization with decreased nuclear rim staining and formation of intranuclear foci%3B distribution of endogenous LMNA%2C LMNB1 and LMNB2 are altered in cells expressing this mutant%3B causes an increased loss of endogenous EMD from the nuclear envelope%3B interacts with itself and with wild-type LMNA and LMNB1%3B no decrease in the stability compared with wild-type. M->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10939567,ECO:0000269|PubMed:11792809;Dbxref=dbSNP:rs59653062,PMID:10939567,PMID:11792809	
P02545	UniProtKB	Natural variant	377	377	.	.	.	ID=VAR_016205;Note=In EDMD2%3B no obvious effect on nuclear morphology in cultured skin fibroblasts from heterozygous patients%3B no effect on protein level. R->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10814726,ECO:0000269|PubMed:12628721,ECO:0000269|PubMed:12673789,ECO:0000269|PubMed:15372542,ECO:0000269|PubMed:15744034,ECO:0000269|PubMed:17136397;Dbxref=dbSNP:rs61672878,PMID:10814726,PMID:12628721,PMID:12673789,PMID:15372542,PMID:15744034,PMID:17136397	
P02545	UniProtKB	Natural variant	377	377	.	.	.	ID=VAR_039777;Note=In EDMD2. R->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12032588,ECO:0000269|PubMed:12649505;Dbxref=dbSNP:rs61672878,PMID:12032588,PMID:12649505	
P02545	UniProtKB	Natural variant	380	380	.	.	.	ID=VAR_063591;Note=In MDCL. L->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18551513;Dbxref=dbSNP:rs121912495,PMID:18551513	
P02545	UniProtKB	Natural variant	386	386	.	.	.	ID=VAR_009987;Note=In EDMD2%3B dramatically aberrant localization with decreased nuclear rim staining and formation of intranuclear foci%3B distribution of endogenous LMNA%2C LMNB1 and LMNB2 are altered in cells expressing this mutant%3B causes an increased loss of endogenous EMD from the nuclear envelope%3B interacts with itself and with wild-type LMNA and LMNB1%3B no decrease in the stability compared with wild-type. R->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10939567,ECO:0000269|PubMed:11792809,ECO:0000269|PubMed:12649505,ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs267607545,PMID:10939567,PMID:11792809,PMID:12649505,PMID:20848652	
P02545	UniProtKB	Natural variant	388	388	.	.	.	ID=VAR_070180;Note=In CMD1A%3B no effect on nuclear morphology but restricts lamin A to the cytoplasm. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20160190;Dbxref=dbSNP:rs267607576,PMID:20160190	
P02545	UniProtKB	Natural variant	399	399	.	.	.	ID=VAR_039778;Note=In FPLD2 and CMD1A%3B no effect on nuclear morphology and lamin A localization. R->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17250669,ECO:0000269|PubMed:20160190;Dbxref=dbSNP:rs58672172,PMID:17250669,PMID:20160190	
P02545	UniProtKB	Natural variant	401	401	.	.	.	ID=VAR_072818;Note=In EDMD2%3B abnormal nuclear localization in a honeycomb expression pattern in about 22%25 of cultured skin fibroblasts from heterozygous patients%3B enhances the interaction with SYNE2%3B no effect on nuclear localization%3B no effect on protein level. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12467752,ECO:0000269|PubMed:15372542,ECO:0000269|PubMed:23977161;Dbxref=dbSNP:rs61094188,PMID:12467752,PMID:15372542,PMID:23977161	
P02545	UniProtKB	Natural variant	411	411	.	.	.	ID=VAR_072819;Note=Probable disease-associated mutation found in patients with metabolic syndromes%3B probable lipodystrophy causing mutation%3B no effect on nuclear lamin A localization%3B no effect on the interaction with SYNE2. G->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21724554,ECO:0000269|PubMed:23977161;Dbxref=dbSNP:rs267607647,PMID:21724554,PMID:23977161	
P02545	UniProtKB	Natural variant	413	413	.	.	.	ID=VAR_072820;Note=Polymorphism%3B found in patients with skeletal and cardiac muscular dystrophies%3B no effect on nuclear lamin A localization%3B no effect on the interaction with SYNE2. G->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23977161;Dbxref=dbSNP:rs766811975,PMID:23977161	
P02545	UniProtKB	Natural variant	415	415	.	.	.	ID=VAR_072821;Note=Rare variant%3B found in patients with atrial fibrillation%3B unknown pathological significance%3B no effect on nuclear lamin A localization%3B enhances the interaction with SYNE2%3B causes nuclear deformations in heat shock experiments. V->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19427440,ECO:0000269|PubMed:23977161;Dbxref=dbSNP:rs267607606,PMID:19427440,PMID:23977161	
P02545	UniProtKB	Natural variant	419	419	.	.	.	ID=VAR_072822;Note=Polymorphism%3B found in patients with lipodystrophy%3B no effect on nuclear lamin A localization%3B no effect on the interaction with SYNE2. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23977161;Dbxref=dbSNP:rs755686359,PMID:23977161	
P02545	UniProtKB	Natural variant	421	421	.	.	.	ID=VAR_072823;Note=Disease-associated mutation found in patient with severe metabolic syndrome%3B probable lipodystrophy causing mutation%3B no effect on nuclear lamin A localization%3B no effect on the interaction with SYNE2. L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17711925,ECO:0000269|PubMed:23977161;Dbxref=dbSNP:rs267607564,PMID:17711925,PMID:23977161	
P02545	UniProtKB	Natural variant	427	427	.	.	.	ID=VAR_072824;Note=Polymorphism%3B found in patients with skeletal and cardiac muscular dystrophies%3B no effect on nuclear lamin A localization%3B no effect on the interaction with SYNE2. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23977161;Dbxref=PMID:23977161	
P02545	UniProtKB	Natural variant	435	435	.	.	.	ID=VAR_039779;Note=In CMD1A. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14684700;Dbxref=dbSNP:rs150840924,PMID:14684700	
P02545	UniProtKB	Natural variant	439	439	.	.	.	ID=VAR_070181;Note=In FPLD2%3B increase in nuclear blebbing and formation of honeycomb-like structures in the nuclei with no accumulation of prelamin A in skin fibroblasts%3B causes oligomerization of the C-terminal globular domain of lamins A and C under no-reducing conditions and increases binding affinity for DNA%3B increases sensitivity to oxidative stress%3B no significant differences in stability and structure compared with the wild-type. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19220582;Dbxref=dbSNP:rs62636506,PMID:19220582	
P02545	UniProtKB	Natural variant	446	446	.	.	.	ID=VAR_039780;Note=In EDMD2. D->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14684700;Dbxref=dbSNP:rs58541611,PMID:14684700	
P02545	UniProtKB	Natural variant	449	449	.	.	.	ID=VAR_064971;Note=In EDMD2. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs267607637,PMID:20848652	
P02545	UniProtKB	Natural variant	453	453	.	.	.	ID=VAR_063592;Note=In MDCL. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18551513;Dbxref=dbSNP:rs267607598,PMID:18551513	
P02545	UniProtKB	Natural variant	453	453	.	.	.	ID=VAR_009988;Note=In EDMD2%3B abnormal nuclear localization%3B forms nuclear foci in about 8%25 of cultured skin fibroblasts from heterozygous patients%3B interacts with itself and with wild-type LMNA and LMNB1%3B no effect on protein level. R->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10080180,ECO:0000269|PubMed:10739764,ECO:0000269|PubMed:10939567,ECO:0000269|PubMed:11503164,ECO:0000269|PubMed:11792809,ECO:0000269|PubMed:14684700,ECO:0000269|PubMed:15372542,ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs58932704,PMID:10080180,PMID:10739764,PMID:10939567,PMID:11503164,PMID:11792809,PMID:14684700,PMID:15372542,PMID:20848652	
P02545	UniProtKB	Natural variant	454	454	.	.	.	ID=VAR_064972;Note=In EDMD2. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs267607638,PMID:20848652	
P02545	UniProtKB	Natural variant	455	455	.	.	.	ID=VAR_063593;Note=In MDCL. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18551513;Dbxref=dbSNP:rs267607597,PMID:18551513	
P02545	UniProtKB	Natural variant	456	456	.	.	.	ID=VAR_063594;Note=In MDCL. N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18551513;Dbxref=dbSNP:rs267607599,PMID:18551513	
P02545	UniProtKB	Natural variant	456	456	.	.	.	ID=VAR_039781;Note=In EDMD2%3B mislocalized in the nucleus%3B does not alter nuclear size or shape. N->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11503164,ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs60992550,PMID:11503164,PMID:20848652	
P02545	UniProtKB	Natural variant	456	456	.	.	.	ID=VAR_039782;Note=In EDMD2. N->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10939567;Dbxref=dbSNP:rs61235244,PMID:10939567	
P02545	UniProtKB	Natural variant	461	461	.	.	.	ID=VAR_064973;Note=In EDMD2. D->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs267607642,PMID:20848652	
P02545	UniProtKB	Natural variant	465	465	.	.	.	ID=VAR_009989;Note=In FPLD2. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10739751;Dbxref=dbSNP:rs61282106,PMID:10739751	
P02545	UniProtKB	Natural variant	467	467	.	.	.	ID=VAR_064974;Note=In EDMD2. W->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs267607639,PMID:20848652	
P02545	UniProtKB	Natural variant	469	469	.	.	.	ID=VAR_009990;Note=In EDMD2. I->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10739764;Dbxref=dbSNP:rs57394692,PMID:10739764	
P02545	UniProtKB	Natural variant	471	471	.	.	.	ID=VAR_017662;Note=In HGPS. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12768443;Dbxref=dbSNP:rs28928902,PMID:12768443	
P02545	UniProtKB	Natural variant	471	471	.	.	.	ID=VAR_070182;Note=In CMD1A%3B no effect on nuclear morphology and lamin A localization. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20160190;Dbxref=dbSNP:rs267607578,PMID:20160190	
P02545	UniProtKB	Natural variant	481	481	.	.	.	ID=VAR_039783;Note=In EDMD2. Y->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11525883;Dbxref=dbSNP:rs57747780,PMID:11525883	
P02545	UniProtKB	Natural variant	482	482	.	.	.	ID=VAR_009991;Note=In FPLD2%3B abnormal nuclear localization in a honeycomb expression pattern in about 10%25 of cultured skin fibroblasts from heterozygous patients%3B no effect on protein level. R->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10655060,ECO:0000269|PubMed:15372542;Dbxref=dbSNP:rs11575937,PMID:10655060,PMID:15372542	
P02545	UniProtKB	Natural variant	482	482	.	.	.	ID=VAR_009992;Note=In FPLD2%3B interacts with itself and with wild-type LMNA and LMNB1%3B no decrease in the stability compared with wild-type. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10587585,ECO:0000269|PubMed:10739751,ECO:0000269|PubMed:11792809;Dbxref=dbSNP:rs11575937,PMID:10587585,PMID:10739751,PMID:11792809	
P02545	UniProtKB	Natural variant	482	482	.	.	.	ID=VAR_009993;Note=In FPLD2%3B interacts with itself and with wild-type LMNA and LMNB1%3B no decrease in the stability compared with wild-type%3B decreases binding affinity for DNA%3B increases sensitivity to oxidative stress. R->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10655060,ECO:0000269|PubMed:10739751,ECO:0000269|PubMed:11792809,ECO:0000269|PubMed:19220582;Dbxref=dbSNP:rs57920071,PMID:10655060,PMID:10739751,PMID:11792809,PMID:19220582	
P02545	UniProtKB	Natural variant	486	486	.	.	.	ID=VAR_009994;Note=In FPLD2%3B interacts with itself and with wild-type LMNA and LMNB1%3B no decrease in the stability compared with wild-type. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11792809;Dbxref=dbSNP:rs59981161,PMID:11792809	
P02545	UniProtKB	Natural variant	488	488	.	.	.	ID=VAR_072825;Note=Polymorphism%3B found in patient with atrial fibrillation. T->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19427440;Dbxref=dbSNP:rs267607607,PMID:19427440	
P02545	UniProtKB	Natural variant	515	515	.	.	.	ID=VAR_071968;Note=In FPLD2. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24485160;Dbxref=PMID:24485160	
P02545	UniProtKB	Natural variant	520	520	.	.	.	ID=VAR_039784;Note=In EDMD2%3B interacts with itself and with wild-type LMNA and LMNB1%3B no decrease in the stability compared with wild-type. W->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10939567,ECO:0000269|PubMed:11792809;Dbxref=dbSNP:rs58362413,PMID:10939567,PMID:11792809	
P02545	UniProtKB	Natural variant	523	523	.	.	.	ID=VAR_067258;Note=In CMD1A. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21846512;Dbxref=dbSNP:rs201583907,PMID:21846512	
P02545	UniProtKB	Natural variant	527	527	.	.	.	ID=VAR_017663;Note=In HGPS. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12768443;Dbxref=dbSNP:rs57318642,PMID:12768443	
P02545	UniProtKB	Natural variant	527	527	.	.	.	ID=VAR_018727;Note=In MADA. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12075506;Dbxref=dbSNP:rs57520892,PMID:12075506	
P02545	UniProtKB	Natural variant	527	527	.	.	.	ID=VAR_009995;Note=In EDMD2 and FPLD2%3B interacts with itself and with wild-type LMNA and LMNB1%3B reduced binding to SUN1%3B abnormal nuclear localization%3B forms nuclear foci in about 13%25 of cultured skin fibroblasts from heterozygous patients%3B no effect on protein level. R->P;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10080180,ECO:0000269|PubMed:10739764,ECO:0000269|PubMed:10939567,ECO:0000269|PubMed:11503164,ECO:0000269|PubMed:11792809,ECO:0000269|PubMed:12196663,ECO:0000269|PubMed:12649505,ECO:0000269|PubMed:15372542,ECO:0000269|PubMed:15744034,ECO:0000269|PubMed:19933576,ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs57520892,PMID:10080180,PMID:10739764,PMID:10939567,PMID:11503164,PMID:11792809,PMID:12196663,PMID:12649505,PMID:15372542,PMID:15744034,PMID:19933576,PMID:20848652	
P02545	UniProtKB	Natural variant	528	528	.	.	.	ID=VAR_009996;Note=In EDMD2%3B interacts with itself and with wild-type LMNA and LMNB1%3B no decrease in the stability compared with wild-type. T->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10739764,ECO:0000269|PubMed:10939567,ECO:0000269|PubMed:11792809,ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs57629361,PMID:10739764,PMID:10939567,PMID:11792809,PMID:20848652	
P02545	UniProtKB	Natural variant	528	528	.	.	.	ID=VAR_039785;Note=In EDMD2. T->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14684700,ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs57629361,PMID:14684700,PMID:20848652	
P02545	UniProtKB	Natural variant	529	529	.	.	.	ID=VAR_034709;Note=In MADA. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15998779;Dbxref=dbSNP:rs60580541,PMID:15998779	
P02545	UniProtKB	Natural variant	530	530	.	.	.	ID=VAR_009997;Note=In EDMD2%3B interacts with itself and with wild-type LMNA and LMNB1%3B reduced binding to SUN1%3B no decrease in the stability compared with wild-type. L->P;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10080180,ECO:0000269|PubMed:11792809,ECO:0000269|PubMed:19933576;Dbxref=dbSNP:rs60934003,PMID:10080180,PMID:11792809,PMID:19933576	
P02545	UniProtKB	Natural variant	541	541	.	.	.	ID=VAR_039786;Note=In CMD1A%3B grossly abnormal nuclear shape with the nuclear envelope producing prominent lobules in about 10%25 of cultured skin fibroblasts from heterozygous patients. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14675861,ECO:0000269|PubMed:15372542,ECO:0000269|PubMed:19167105;Dbxref=dbSNP:rs56984562,PMID:14675861,PMID:15372542,PMID:19167105	
P02545	UniProtKB	Natural variant	541	541	.	.	.	ID=VAR_039787;Note=In EDMD2. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14684700;Dbxref=dbSNP:rs61444459,PMID:14684700	
P02545	UniProtKB	Natural variant	541	541	.	.	.	ID=VAR_064975;Note=In EDMD2%3B mis-localized in the nucleus%3B does not alter nuclear size or shape. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs61444459,PMID:20848652	
P02545	UniProtKB	Natural variant	541	541	.	.	.	ID=VAR_039788;Note=In EDMD2 and CMD1A%3B modest and non-specific nuclear membrane alterations%3B the phenotype is entirely reversed by coexpression of the S-541 mutation and wild-type lamin-C. R->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16061563,ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs56984562,PMID:16061563,PMID:20848652	
P02545	UniProtKB	Natural variant	542	542	.	.	.	ID=VAR_034710;Note=In HGPS. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15286156;Dbxref=dbSNP:rs56673169,PMID:15286156	
P02545	UniProtKB	Natural variant	573	573	.	.	.	ID=VAR_039789;Note=In CMD1A%2C FPLD2 and MADA. S->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12628721,ECO:0000269|PubMed:16278265,ECO:0000269|PubMed:17250669;Dbxref=dbSNP:rs60890628,PMID:12628721,PMID:16278265,PMID:17250669	
P02545	UniProtKB	Natural variant	578	578	.	.	.	ID=VAR_039790;Note=In an atypical progeroid patient%3B diagnosed as Werner syndrome. E->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15060110;Dbxref=dbSNP:rs61224243,PMID:15060110	
P02545	UniProtKB	Natural variant	582	582	.	.	.	ID=VAR_009998;Note=In FPLD2. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10739751;Dbxref=dbSNP:rs57830985,PMID:10739751	
P02545	UniProtKB	Natural variant	602	602	.	.	.	ID=VAR_064976;Note=In EDMD2. G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20848652;Dbxref=dbSNP:rs60662302,PMID:20848652	
P02545	UniProtKB	Natural variant	608	608	.	.	.	ID=VAR_017664;Note=In HGPS%3B reduced binding to SUN1%3B may affect splicing by activating a cryptic splice donor site. G->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12714972,ECO:0000269|PubMed:12768443,ECO:0000269|PubMed:19933576;Dbxref=dbSNP:rs61064130,PMID:12714972,PMID:12768443,PMID:19933576	
P02545	UniProtKB	Natural variant	624	624	.	.	.	ID=VAR_039791;Note=In EDMD2. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11503164;Dbxref=dbSNP:rs13768,PMID:11503164	
P02545	UniProtKB	Natural variant	631	631	.	.	.	ID=VAR_072826;Note=Probable disease-associated mutation found in a patient with metabolic syndrome. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21724554;Dbxref=dbSNP:rs267607648,PMID:21724554	
P02545	UniProtKB	Natural variant	644	644	.	.	.	ID=VAR_039792;Note=In HGPS and EDMD2%3B partially inhibits tail cleavage. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15060110,ECO:0000269|PubMed:20848652,ECO:0000269|PubMed:22355414;Dbxref=dbSNP:rs142000963,PMID:15060110,PMID:20848652,PMID:22355414	
P02545	UniProtKB	Mutagenesis	201	201	.	.	.	Note=Decreased sumoylation%3B aberrant localization with decreased nuclear rim staining and formation of intranuclear foci%3B associated with increased cell death. K->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18606848;Dbxref=PMID:18606848	
P02545	UniProtKB	Mutagenesis	644	644	.	.	.	Note=Does not affect tail cleavage. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22355414;Dbxref=PMID:22355414	
P02545	UniProtKB	Mutagenesis	647	647	.	.	.	Note=Completely inhibits tail cleavage. L->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22355414;Dbxref=PMID:22355414	
P02545	UniProtKB	Mutagenesis	648	648	.	.	.	Note=Completely inhibits tail cleavage. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22355414;Dbxref=PMID:22355414	
P02545	UniProtKB	Mutagenesis	650	650	.	.	.	Note=Partially inhibits tail cleavage. N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22355414;Dbxref=PMID:22355414	
P02545	UniProtKB	Mutagenesis	661	661	.	.	.	Note=Loss of interaction with NARF. Abolishes farnesylation. C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10514485,ECO:0000269|PubMed:22355414;Dbxref=PMID:10514485,PMID:22355414	
P02545	UniProtKB	Sequence conflict	340	340	.	.	.	Note=E->K;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P02545	UniProtKB	Helix	316	384	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1X8Y	
P02545	UniProtKB	Beta strand	430	436	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GHD	
P02545	UniProtKB	Beta strand	438	445	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IFR	
P02545	UniProtKB	Beta strand	449	456	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IFR	
P02545	UniProtKB	Beta strand	458	460	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IFR	
P02545	UniProtKB	Helix	464	466	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IVT	
P02545	UniProtKB	Beta strand	468	473	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IFR	
P02545	UniProtKB	Beta strand	479	482	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IFR	
P02545	UniProtKB	Beta strand	494	499	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IFR	
P02545	UniProtKB	Helix	500	502	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3GEF	
P02545	UniProtKB	Turn	508	510	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IFR	
P02545	UniProtKB	Beta strand	511	514	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IFR	
P02545	UniProtKB	Beta strand	526	531	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IFR	
P02545	UniProtKB	Beta strand	537	543	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IFR	
